BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30909994)

  • 21. The prognostic value of D-dimer in lung cancer.
    İnal T; Anar C; Polat G; Ünsal İ; Halilçolar H
    Clin Respir J; 2015 Jul; 9(3):305-13. PubMed ID: 24720709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node size and metastatic infiltration in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Brochhagen HG; Schneider PM; Hölscher AH
    Chest; 2003 Feb; 123(2):463-7. PubMed ID: 12576367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
    Zhang C; Jia Y; Jia Y; Zhang X; Li K
    Int J Clin Oncol; 2018 Dec; 23(6):1070-1075. PubMed ID: 30168089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of plasma D-dimer levels in patients with lung cancer.
    Taguchi O; Gabazza EC; Yasui H; Kobayashi T; Yoshida M; Kobayashi H
    Thorax; 1997 Jun; 52(6):563-5. PubMed ID: 9227726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients.
    Kwon HC; Oh SY; Lee S; Kim SH; Han JY; Koh RY; Kim MC; Kim HJ
    Jpn J Clin Oncol; 2008 Jan; 38(1):2-7. PubMed ID: 18258711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.
    Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M
    Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancer.
    Liu HB; Gu XL; Ma XQ; Lv TF; Wu Y; Xiao YY; Yuan DM; Li YF; Song Y
    Neoplasma; 2013; 60(2):203-8. PubMed ID: 23259790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic predictors of metastasis of different regional lymph nodes in patients intraoperatively diagnosed with stage-I non-small cell lung cancer.
    Zhao F; Zhen FX; Zhou Y; Huang CJ; Yu Y; Li J; Li QF; Zhu CX; Yang XY; You SH; Wu QG; Qin XY; Liu Y; Chen L; Wang W
    BMC Cancer; 2019 May; 19(1):444. PubMed ID: 31088404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
    Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
    Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.
    Schaarschmidt BM; Buchbender C; Nensa F; Grueneisen J; Gomez B; Köhler J; Reis H; Ruhlmann V; Umutlu L; Heusch P
    PLoS One; 2015; 10(1):e0116277. PubMed ID: 25574968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT texture analysis can help differentiate between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer.
    Andersen MB; Harders SW; Ganeshan B; Thygesen J; Torp Madsen HH; Rasmussen F
    Acta Radiol; 2016 Jun; 57(6):669-76. PubMed ID: 26271125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients.
    Zhu LR; Li J; Chen P; Jiang Q; Tang XP
    Clin Transl Oncol; 2016 Feb; 18(2):178-88. PubMed ID: 26184726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of plasma D-dimer and thrombus precursor protein in patients with operable breast cancer as a potential predictor of lymph node metastasis.
    Kim HK; Song KS; Lee KR; Kang YH; Lee YJ; Lee ES
    Blood Coagul Fibrinolysis; 2004 Jan; 15(1):9-13. PubMed ID: 15166937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of lymph node metastasis in the contralateral mediastinum or scalene through mediastinoscopy and para-mediastinal small incision in potentially operable non-small cell lung cancer].
    Zhang SY; Wang X; Rong TH; Zheng L; Zeng CG; Xie ZM; Yu H; Zhu ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):629-31. PubMed ID: 18210888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography, and nodal specimen.
    Arita T; Matsumoto T; Kuramitsu T; Kawamura M; Matsunaga N; Sugi K; Esato K
    Chest; 1996 Oct; 110(4):1004-8. PubMed ID: 8874260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients.
    Hegde P; Molina JC; Thivierge-Southidara M; Jain RV; Gowda A; Ferraro P; Liberman M
    Semin Thorac Cardiovasc Surg; 2020; 32(1):162-168. PubMed ID: 31325576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.